Genomics

Dataset Information

0

Genome profile of human rectal tumors and response to neoadjuvant chemoradiotherapy


ABSTRACT: Background: Neoadjuvant chemoradiotherapy (NCRT) is the treatment of choice in advanced rectal cancer, even though there are many patients who will not benefit from it. There are still no effective methods for predicting which patients will respond or not. The present study aimed to define the genomic profile of rectal tumors and to identify alterations that are predictive of response in order to optimize therapeutic strategies. Methods: Forty-eight candidates for NCRT were recruited and their pretherapy biopsies analyzed by array Comparative Genomic Hybridization (aCGH). Pathologic response was evaluated by tumor regression grade (TRG).Results: Both Smoothing and Hidden Markov Model (HMM) approaches identified similar alterations, with a prevalence of DNA gains. Non responsive patients had a different alteration profile from responsive ones, with a higher number of genome changes mainly located on 2q21, 7q21, 7q36, 13q12, 13q32-34, 16p13, 17p12 chromosomal regions. Conclusion: This exploratory study suggests that an in depth characterization of chromosomal alterations by aCGH would provide useful predictive information about response to NCRT and help to optimize therapy in rectal cancer patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE25885 | GEO | 2011/11/17

SECONDARY ACCESSION(S): PRJNA135819

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2011-11-17 | E-GEOD-25885 | biostudies-arrayexpress
2023-01-05 | PXD035408 | Pride
2022-09-17 | GSE213331 | GEO
2019-09-05 | GSE136872 | GEO
2019-07-01 | GSE123390 | GEO
2021-06-08 | GSE132668 | GEO
2024-08-09 | GSE242786 | GEO
2012-09-20 | GSE40989 | GEO
| EGAS00001003250 | EGA
2022-03-08 | PXD032117 |